Ag120201 2025. The yield on a treasury bill represents the return an investor will receive. Ivosidenib tablets have received fda approval for the treatment of adult patients with relapsed/refractory myelodysplastic syndromes with a susceptible idh1 mutation.

First day of the first applicable pay period beginning on or after 01/01/2025. Search our inventory by part number and get results fast.